SBIO vs. GERM
Compare and contrast key facts about ALPS Medical Breakthroughs ETF (SBIO) and ETFMG Treatments Testing and Advancements ETF (GERM).
SBIO and GERM are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. SBIO is a passively managed fund by SS&C that tracks the performance of the S-Network Medical Breakthroughs Index. It was launched on Dec 31, 2014. GERM is a passively managed fund by ETFMG that tracks the performance of the Prime Treatments, Testing and Advancements Index. It was launched on Jun 17, 2020. Both SBIO and GERM are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SBIO or GERM.
Correlation
The correlation between SBIO and GERM is 0.03, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SBIO vs. GERM - Performance Comparison
Key characteristics
Returns By Period
SBIO
-21.44%
-16.68%
-32.15%
-17.45%
-6.14%
-1.27%
GERM
N/A
N/A
N/A
N/A
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SBIO vs. GERM - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is lower than GERM's 0.68% expense ratio.
Risk-Adjusted Performance
SBIO vs. GERM — Risk-Adjusted Performance Rank
SBIO
GERM
SBIO vs. GERM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and ETFMG Treatments Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SBIO vs. GERM - Dividend Comparison
SBIO's dividend yield for the trailing twelve months is around 4.52%, while GERM has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 4.52% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
GERM ETFMG Treatments Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
SBIO vs. GERM - Drawdown Comparison
Volatility
SBIO vs. GERM - Volatility Comparison
ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 16.17% compared to ETFMG Treatments Testing and Advancements ETF (GERM) at 0.00%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.